Inside EU Health

Inside EU Health: EPP request pause on wastewater law; S&D urges Várhelyi to back €90 billion for health in next MFF; infant formula recall; ERC backs bench-to-clinic innovations; WHO inaugurates Cyprus office

Várhelyi sympathetic to one-year ‘stop-the-clock’ pause; S&D urges Várhelyi to back €90 billion for health in next MFF; ECDC warns of toxin-containing infant formula; ERC backs bench-to-clinic innovations; WHO/Europe establishes Cyprus office

EU-India

EU-India free trade deal will slash tariffs for medicines and medical devices

The EU and India have agreed a free trade deal that promises to significantly cut tariffs on medicines and medical devices

Inside EU Health

Inside EU Health: EU-India free trade deal will slash tariffs for medicines and medical devices; six countries in the WHO/Europe region lose measles-free status

EU-India free trade deal will slash tariffs for medicines and medical; six countries in the WHO/Europe region lose measles-free status

Inside EU Health

Inside EU Health: WHO defends itself from US slurs; pilot targets 70-day clinical trial approvals; less than 1% of research spent on key women’s health issues

WHO defends itself against US accusations; FAST-EU pilot targets 70-day clinical trial approvals; less than 1% of research funding goes to key women’s health conditions

Inside EU Health

Inside EU Health: EFPIA raises its CMA concerns; Élysée dismisses Trump 'Fake News'; EU funds €147 million for health research and investment in Africa

EFPIA raises its CMA concerns; Élysée dismisses Trump’s Davos claim on medicine prices as 'Fake News'; EU funds €147 million for health research and investment in Africa

Inside EU Health

Inside EU Health: WHO to consider US payment arrears; IHI unveils first applicant-driven projects; improvement in unmet medical needs of children

WHO Executive Board will consider US payment arrears; IHI unveils first projects from its applicant-driven call; Eurostat data points to an improvement in the unmet medical needs of children

Inside EU Health

Inside EU Health: Parliament votes on Critical Medicines Act; EMA regulatory co-operation; Paracetamol (still) safe during pregnancy

Parliament votes on Critical Medicines Act position; EMA to build on regulatory co-operation piloted under COVID; Paracetamol is (still) safe during pregnancy

Critical Medicines Act

Parliament draws the battle lines on Europe’s Critical Medicines Act

The European Parliament has overwhelmingly endorsed a more ambitious Critical Medicines Act

Inside EU Health

Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI; ECDC issues warning on Doxy-PEP

Inside EU Health: US tariffs and MFN pricing threaten EU investment and access; EMA and FDA agree good AI principles; ECDC issues warning on Doxy-PEP

EU/US Trade

US tariffs and MFN pricing threaten pharma investment and access in Europe

Rising uncertainty driven by US tariffs and proposed “most-favoured nation” pricing is prompting pharmaceutical companies to delay investment and product launches in Europe

Inside EU Health

Inside EU Health: Biotech Act; targeted fix of medical devices; ‘Safe Hearts Plan’ arrives

🎄Happy Christmas! The Health Package has arrived: Biotech Act, Targeted fix of medical device and; ‘Safe Hearts Plan’

Cardiovascular disease

‘Safe Hearts Plan’ sets out an EU response, but critics see gaps

Critics warn that the EU’s cardiovascular disease plan lacks the strong preventive measures needed to match the scale of the problem

Biotech Act

Europe pushes to regain ground on competitors with new Biotech Act

With the publication of the Biotech Act, the EU sets out how it intends to boost the sector’s competitive position in the face of China’s rapid rise

Medical devices

EU moves to fix failing medical and in vitro device rules and spur innovation

A 'targeted' revision to the MDR and IVDR promises clearer timelines, proportionate oversight and faster access to innovative technologies

Inside EU Health

Inside EU Health: Parliament pushes for bolder CMA; cardiovascular disease costs 2% EU GDP; EU backs rapid ‘test-before-treat’ diagnostic

Parliament pushes for a more ambitious and European Critical Medicines Act; report estimates that cardiovascular disease costs the EU 2% of GDP; and Commission backs rapid ‘Test Before Treat’ technology to reduce misuse of antibiotics

Critical Medicines Act

Parliament pushes for a more ambitious and European approach to Critical Medicines Act

The European Parliament’s public health committee has endorsed compromise amendments to the Critical Medicines Act, setting out a more ambitious approach than member states

Cardiovascular disease

Cardiovascular disease is estimated to cost the EU 2% of GDP

Ahead of tomorrow’s ‘Safe Hearts Plan’ on cardiovascular disease, the Commission released a report which shows the heavy toll on Europe’s health and its pockets

Inside EU Health

Inside EU Health: Pharma deal agreed; State of EU Health Report; WHO concludes that vaccines don’t cause autism - again

The Council and Parliament reached a deal on the Pharma Package, the latest 'State of EU Health Report' is released, and WHO confirms - once again - that vaccines do not cause autism.

Pharma Package

EU reaches landmark pharma deal after marathon overnight talks

In the early hours, the Parliament and Council managed to reach a deal on one of the EU's most complex legislative proposals, the Pharma Package

Inside EU Health

Inside EU Health: Pharma slams Commission decision to exclude Wastewater Directive from omnibus; Várhelyi reveals name of cardio plan; crunch time for Pharma Package

Pharma slams Commission for excluding Wastewater Directive from Environment Omnibus; Várhelyi reveals name of cardiovascular plan; Pharma trilogue continues into the night

Cardiovascular

Várhelyi reveals EU cardiovascular health plan will be called the ‘Safe Hearts Plan’

The EU will call its cardiovascular strategy the ‘Safe Hearts Plan’ and will focus on prevention

Urban Wastewater Treatment Directive

Pharma sector slams Commission after Wastewater Directive excluded from Environment Omnibus

Commission environmental simplification package leaves Wastewater Directive untouched

Inside EU Health

Inside EU Health: Rising sales of animal antimicrobials; special task force on imports; update on PABS

Rising EU sales of animal antimicrobials; special task force on food safety standards of imports; update on the Pandemic Agreement’s unfinished business

Pandemic Agreement

Update on Pandemic Agreement’s unfinished business

MEPs received an update on ongoing negotiations for the pathogen access and benefit-sharing system

One Health

Rising EU sales of animal antimicrobials raise concern

The latest annual surveillance report from the European Medicines Agency (EMA) shows a worrying increase in antimicrobial sales for animal use across the European Union